Gene expression profile of bladder tissue of patients with ulcerative interstitial cystitis
Marianne Gamper, Volker Viereck, Verena Geissbühler, Jakob Eberhard, Jochen Binder, Carlo Moll, Hubert Rehrauer, René Moser, Marianne Gamper, Volker Viereck, Verena Geissbühler, Jakob Eberhard, Jochen Binder, Carlo Moll, Hubert Rehrauer, René Moser
Abstract
Background: Interstitial cystitis (IC), a chronic bladder disease with an increasing incidence, is diagnosed using subjective symptoms in combination with cystoscopic and histological evidence. By cystoscopic examination, IC can be classified into an ulcerative and a non-ulcerative subtype. To better understand this debilitating disease on a molecular level, a comparative gene expression profile of bladder biopsies from patients with ulcerative IC and control patients has been performed.
Results: Gene expression profiles from bladder biopsies of five patients with ulcerative IC and six control patients were generated using Affymetrix GeneChip expression arrays (Affymetrix--GeneChip Human Genome U133 Plus 2.0). More than 31,000 of > 54,000 tested probe sets were present (detection p-value < 0.05). The difference between the two groups was significant for over 3,500 signals (t-test p-value < 0.01), and approximately 2,000 of the signals (corresponding to approximately 1,000 genes) showed an IC-to-healthy expression ratio greater than two. The IC pattern had similarities to patterns from immune system, lymphatic, and autoimmune diseases. The dominant biological processes were the immune and inflammatory responses. Many of the up-regulated genes were expressed in leukocytes, suggesting that leukocyte invasion into the bladder wall is a dominant feature of ulcerative IC. Histopathological data supported these findings.
Conclusion: GeneChip expression arrays present a global picture of ulcerative IC and provide us with a series of marker genes characteristic for this subtype of the disease. Evaluation of biopsies from other bladder patients with similar symptoms (e.g. patients with non-ulcerative IC) will further indicate whether the data presented here will be valuable for the diagnosis of IC.
Figures
References
- Kelada E, Jones A. Interstitial cystitis. Arch Gynecol Obstet. 2007;275:223–229. doi: 10.1007/s00404-006-0247-7.
- Rosamilia A. Painful bladder syndrome/interstitial cystitis. Best Pract Res Clin Obstet Gynaecol. 2005;19:843–859. doi: 10.1016/j.bpobgyn.2005.08.004.
- Mayer R. Interstitial cystitis pathogenesis and treatment. Curr Opin Infect Dis. 2007;20:77–82. doi: 10.1097/QCO.0b013e32801158df.
- Peeker R, Fall M. Treatment guidelines for classic and non-ulcer interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11:23–32. doi: 10.1007/s001920050006.
- Peeker R, Fall M. Toward a precise definition of interstitial cystitis: further evidence of differences in classic and nonulcer disease. J Urol. 2002;167:2470–2472. doi: 10.1016/S0022-5347(05)65006-9.
- Koziol JA, Adams HP, Frutos A. Discrimination between the ulcerous and the nonulcerous forms of interstitial cystitis by noninvasive findings. J Urol. 1996;155:87–90. doi: 10.1016/S0022-5347(01)66551-0.
- Erickson DR, Tomaszewski JE, Kunselman AR, Stetter CM, Peters KM, Rovner ES, Demers LM, Wheeler MA, Keay SK. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol. 2008;179:1850–1856. doi: 10.1016/j.juro.2008.01.047.
- Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L., Jr The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol. 1999;161:553–557. S0022-5347(01)61948-7.
- Sant GR, Kempuraj D, Marchand JE, Theoharides TC. The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology. 2007;69:34–40. doi: 10.1016/j.urology.2006.08.1109.
- Theoharides TC, Kempuraj D, Sant GR. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology. 2001;57:47–55. doi: 10.1016/S0090-4295(01)01129-3.
- Peeker R, Enerback L, Fall M, Aldenborg F. Recruitment, distribution and phenotypes of mast cells in interstitial cystitis. J Urol. 2000;163:1009–1015. doi: 10.1016/S0022-5347(05)67873-1.
- Keay SK, Zhang CO, Shoenfelt J, Erickson DR, Whitmore K, Warren JW, Marvel R, Chai T. Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology. 2001;57:9–14. doi: 10.1016/S0090-4295(01)01127-X.
- Keay SK, Szekely Z, Conrads TP, Veenstra TD, Barchi JJ, Jr, Zhang CO, Koch KR, Michejda CJ. An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc Natl Acad Sci USA. 2004;101:11803–11808. doi: 10.1073/pnas.0404509101.
- Erickson DR, Xie SX, Bhavanandan VP, Wheeler MA, Hurst RE, Demers LM, Kushner L, Keay SK. A comparison of multiple urine markers for interstitial cystitis. J Urol. 2002;167:2461–2469. doi: 10.1016/S0022-5347(05)65005-7.
- Keay S, Seillier-Moiseiwitsch F, Zhang CO, Chai TC, Zhang J. Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment. Physiol Genomics. 2003;14:107–115. doi: 10.1152/physiolgenomics.00055.2003.
- Canter MP, Graham CA, Heit MH, Blackwell LS, Wilkey DW, Klein JB, Merchant ML. Proteomic techniques identify urine proteins that differentiate patients with interstitial cystitis from asymptomatic control subjects. Am J Obstet Gynecol. 2008;198:553. doi: 10.1016/j.ajog.2008.01.052.
- Kuromitsu S, Yokota H, Hiramoto M, Morita S, Mita H, Yamada T. Increased concentration of neutrophil elastase in urine from patients with interstitial cystitis. Scand J Urol Nephrol. 2008;42:455–461. doi: 10.1080/00365590802025881.
- Byrne DS, Sedor JF, Estojak J, Fitzpatrick KJ, Chiura AN, Mulholland SG. The urinary glycoprotein GP51 as a clinical marker for interstitial cystitis. J Urol. 1999;161:1786–1790. S0022-5347(05)68800-3.
- Simon LJ, Landis JR, Erickson DR, Nyberg LM. The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics. Urology. 1997;49:64–75. doi: 10.1016/S0090-4295(99)80334-3.
- Tomaszewski JE, Landis JR, Russack V, Williams TM, Wang LP, Hardy C, Brensinger C, Matthews YL, Abele ST, Kusek JW, et al. Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study. Urology. 2001;57:67–81. doi: 10.1016/S0090-4295(01)01166-9.
- Denson MA, Griebling TL, Cohen MB, Kreder KJ. Comparison of cystoscopic and histological findings in patients with suspected interstitial cystitis. J Urol. 2000;164:1908–1911. doi: 10.1016/S0022-5347(05)66915-7.
- Boackle SA. Complement and autoimmunity. Biomed Pharmacother. 2003;57:269–273. doi: 10.1016/S0753-3322(03)00084-2.
- Vuillier F, Dumas G, Magnac C, Prevost MC, Lalanne AI, Oppezzo P, Melanitou E, Dighiero G, Payelle-Brogard B. Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the mu and CD79a chains. Blood. 2005;105:2933–2940. doi: 10.1182/blood-2004-09-3643.
- Tedder TF, Streuli M, Schlossman SF, Saito H. Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes. Proc Natl Acad Sci USA. 1988;85:208–212. doi: 10.1073/pnas.85.1.208.
- Hofker MH, Walter MA, Cox DW. Complete physical map of the human immunoglobulin heavy chain constant region gene complex. Proc Natl Acad Sci USA. 1989;86:5567–5571. doi: 10.1073/pnas.86.14.5567.
- Su W, Gordon JN, Barone F, Boursier L, Turnbull W, Mendis S, Dunn-Walters DK, Spencer J. Lambda light chain revision in the human intestinal IgA response. J Immunol. 2008;181:1264–1271.
- Volkova OY, Reshetnikova ES, Mechetina LV, Chikaev NA, Najakshin AM, Faizulin RZ, Duzhak TG, Taranin AV. Generation and characterization of monoclonal antibodies specific for human FCRLA. Hybridoma (Larchmt) 2007;26:78–85. doi: 10.1089/hyb.2006.043.
- Kazemi T, Asgarian-Omran H, Hojjat-Farsangi M, Shabani M, Memarian A, Sharifian RA, Razavi SM, Jeddi-Tehrani M, Rabbani H, Shokri F. Fc receptor-like 1–5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia. Int J Cancer. 2008;123:2113–2119. doi: 10.1002/ijc.23751.
- Adams H, Liebisch P, Schmid P, Dirnhofer S, Tzankov A. Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms. Appl Immunohistochem Mol Morphol. 2008 doi: 10.1097/PAI.0b013e3181845ef4.
- Hsueh RC, Scheuermann RH. Tyrosine kinase activation in the decision between growth, differentiation, and death responses initiated from the B cell antigen receptor. Adv Immunol. 2000;75:283–316. doi: 10.1016/S0065-2776(00)75007-3.
- Widhopf GF, 2nd, Goldberg CJ, Toy TL, Rassenti LZ, Wierda WG, Byrd JC, Keating MJ, Gribben JG, Rai KR, Kipps TJ. Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3. Blood. 2008;111:3137–3144. doi: 10.1182/blood-2007-02-073130.
- Lazzeri M. The physiological function of the urothelium – more than a simple barrier. Urol Int. 2006;76:289–295. doi: 10.1159/000092049.
- Hruz T, Laule O, Szabo G, Wessendorp F, Bleuler S, Oertle L, Widmayer P, Gruissem W, Zimmermann P. Genevestigator V3: a reference expression database for the meta-analysis of transcriptomes. Advances in Bioinformatics. 2008;2008:420747. doi: 10.1155/2008/420747.
- Erickson DR, Belchis DA, Dabbs DJ. Inflammatory cell types and clinical features of interstitial cystitis. J Urol. 1997;158:790–793. doi: 10.1016/S0022-5347(01)64317-9.
- Lee HK, Braynen W, Keshav K, Pavlidis P. ErmineJ: tool for functional analysis of gene expression data sets. BMC Bioinformatics. 2005;6:269. doi: 10.1186/1471-2105-6-269.
- Tseng SY, Dustin ML. T-cell activation: a multidimensional signaling network. Curr Opin Cell Biol. 2002;14:575–580. doi: 10.1016/S0955-0674(02)00370-8.
- Niiro H, Clark EA. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol. 2002;2:945–956. doi: 10.1038/nri955.
- Handel ML, Girgis L. Transcription factors. Best Pract Res Clin Rheumatol. 2001;15:657–675. doi: 10.1053/berh.2001.0186.
- Pridans C, Holmes ML, Polli M, Wettenhall JM, Dakic A, Corcoran LM, Smyth GK, Nutt SL. Identification of Pax5 target genes in early B cell differentiation. J Immunol. 2008;180:1719–1728.
- Holmes ML, Pridans C, Nutt SL. The regulation of the B-cell gene expression programme by Pax5. Immunol Cell Biol. 2008;86:47–53. doi: 10.1038/sj.icb.7100134.
- Ekins S, Nikolsky Y, Bugrim A, Kirillov E, Nikolskaya T. Pathway mapping tools for analysis of high content data. Methods Mol Biol. 2006;356:319–350. doi: 10.1385/1597452173.
- Hauser PJ, Dozmorov MG, Bane BL, Slobodov G, Culkin DJ, Hurst RE. Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis. J Urol. 2008;179:764–769. doi: 10.1016/j.juro.2007.09.022.
- Slobodov G, Feloney M, Gran C, Kyker KD, Hurst RE, Culkin DJ. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol. 2004;171:1554–1558. doi: 10.1097/01.ju.0000118938.09119.a5.
- Erickson DR, Tomaszewski JE, Kunselman AR, Bentley CM, Peters KM, Rovner ES, Demers LM, Wheeler MA, Keay SK. Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol. 2005;173:93–97.
- Driscoll KE, Carter JM, Hassenbein DG, Howard B. Cytokines and particle-induced inflammatory cell recruitment. Environ Health Perspect. 1997;105:1159–1164. doi: 10.2307/3433526.
- Nigrovic PA, Lee DM. Mast cells in inflammatory arthritis. Arthritis Res Ther. 2005;7:1–11. doi: 10.1186/ar1446.
- Bjerklund Johansen TE, Weidner W. Understanding chronic pelvic pain syndrome. Curr Opin Urol. 2002;12:63–67. doi: 10.1097/00042307-200201000-00012.
- Toft BR, Nordling J. Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a review. Curr Opin Urol. 2006;16:268–272. doi: 10.1097/01.mou.0000232048.81965.16.
- Hubbell E, Liu WM, Mei R. Robust estimators for expression analysis. Bioinformatics. 2002;18:1585–1592. doi: 10.1093/bioinformatics/18.12.1585.
- AFFYMETRIX: Statistical Algorithms Description Document
- Liu WM, Mei R, Di X, Ryder TB, Hubbell E, Dee S, Webster TA, Harrington CA, Ho MH, Baid J, et al. Analysis of high density expression microarrays with signed-rank call algorithms. Bioinformatics. 2002;18:1593–1599. doi: 10.1093/bioinformatics/18.12.1593.
- Sheehan DC, Hrapchak BB. In: Theory and practice of histotechnology. 2. Mosby CV, editor. St. Louis, MO: The CV Mosby Company; 1980.
Source: PubMed